IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) Gapping Lower -4.90%

Investors are watching IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) ahead of the market open as shares are gapping down -4.90% with the stock currently sitting at $1.00.

Investors might be trying to figure out an investment plan that is right for them. Some may opt to go with a short-term plan, and others may choose to invest in stocks for the long haul. The thought of creating a defined plan may be overwhelming to some. Comparing the plusses and minuses of both may be a good way to start forming a strategy. Investing for the short-term may offer chances to capitalize on gains over a few weeks or months. There may be more fluctuations to deal with in the short-term, but the rewards may be greater if managed properly. One drawback of investing for the short-term is that it may involve more risk. The element of correct timing comes into play when trying to enter or exit a position, which may not be for everyone. Investing for the long-term may be a safer way to go as investors are typically looking for smaller gains over a longer period of time.

A gap is a space between prices that occurs when the price of a stock makes a move down or up when there is no trading happening in between. 

Recent Price History

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI)’s performance this year to date is -64.82%.  The stock has performed -19.76% over the last seven days, -59.06% over the last thirty, and -50.79% over the last three months.  Over the last six months, IntelliPharmaCeutics International Inc.’s stock has been -65.07% and -45.41% for the year.


The simple moving average is the most common method used to calculate the moving average of prices. IntelliPharmaCeutics International Inc.’s 20-Day Simple Moving Average is -48.59%.  Extending back, their 50-Day Simple Moving Average is -51.90%, looking even further back, their 200-Day Simple Moving Average stands at -58.74%.  

Disclaimer: Nothing contained in this publication is intended to constitute legal, tax, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. The general information contained in this publication should not be acted upon without obtaining specific legal, tax, and investment advice from a licensed professional.

Leave a Comment